PRISM BioLab Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Public

  • Employees
  • 35

Employees

  • Stock Symbol
  • 206A

Stock Symbol

  • Share Price
  • $0.53
  • (As of Thursday Closing)

PRISM BioLab General Information

Description

Prism Biolab Co Ltd is engaged in drug discovery and development based on PepMetics Technology, a proprietary platform technology.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 2-26-1, Muraoka-Higashi
  • Shonan Eye Park
  • Fujisawa, Kanagawa 251-8555
  • Japan
+81
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
TKS
Corporate Office
  • 2-26-1, Muraoka-Higashi
  • Shonan Eye Park
  • Fujisawa, Kanagawa 251-8555
  • Japan
+81

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PRISM BioLab Stock Performance

As of 19-Nov-2026, PRISM BioLab’s stock price is $0.53. Its current market cap is $19.7M with 37M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.53 $0.55 $0.51 - $1.79 $19.7M 37M 132K -$0.15

PRISM BioLab Financials Summary

As of 30-Jun-2026, PRISM BioLab has a trailing 12-month revenue of $4.77M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 30-Sep-2025 FY 2024 30-Sep-2024 FY 2023 30-Sep-2023
EV 17,713 19,226 79,995
Revenue 4,775 4,539 2,033 813
EBITDA (3,722)
Net Income (5,669) (5,587) (6,983) (3,793)
Total Assets 15,279 20,764 31,709 8,110
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

PRISM BioLab Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore PRISM BioLab‘s full profile, request access.

Request a free trial

PRISM BioLab Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore PRISM BioLab‘s full profile, request access.

Request a free trial

PRISM BioLab Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Prism Biolab Co Ltd is engaged in drug discovery and development based on PepMetics Technology, a proprietary platform t
Drug Discovery
Fujisawa, Japan
35 As of 2026

Kawasaki, Japan
 

Paris, France
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

PRISM BioLab Competitors (4)

One of PRISM BioLab’s 4 competitors is PeptiDream, a Formerly VC-backed company based in Kawasaki, Japan.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
PeptiDream Formerly VC-backed Kawasaki, Japan
Ipsen Formerly PE-Backed Paris, France
Protagonist Therapeutics Formerly VC-backed Newark, CA
Ayala Pharmaceuticals Corporation Wilmington, DE
To view PRISM BioLab’s complete competitors history, request access »

PRISM BioLab Patents

PRISM BioLab Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2025512138-A New seven-membered ring fused compound Pending 11-Apr-2022
EP-4508052-A1 Novel seven-membered ring-fused compounds Pending 11-Apr-2022
EP-4508052-A4 Novel seven-membered ring-fused compounds Pending 11-Apr-2022
US-20250250282-A1 Novel seven-membered ring-fused compounds Pending 11-Apr-2022
WO-2023200017-A1 Novel seven-membered ring-fused compounds Inactive 11-Apr-2022 C07D495/14
To view PRISM BioLab’s complete patent history, request access »

PRISM BioLab Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PRISM BioLab Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore PRISM BioLab‘s full profile, request access.

Request a free trial

PRISM BioLab ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view PRISM BioLab’s complete esg history, request access »

PRISM BioLab FAQs

  • When was PRISM BioLab founded?

    PRISM BioLab was founded in 2006.

  • Where is PRISM BioLab headquartered?

    PRISM BioLab is headquartered in Fujisawa, Japan.

  • What is the size of PRISM BioLab?

    PRISM BioLab has 35 total employees.

  • What industry is PRISM BioLab in?

    PRISM BioLab’s primary industry is Drug Discovery.

  • Is PRISM BioLab a private or public company?

    PRISM BioLab is a Public company.

  • What is PRISM BioLab’s stock symbol?

    The ticker symbol for PRISM BioLab is 206A.

  • What is the current stock price of PRISM BioLab?

    As of 19-Nov-2026 the stock price of PRISM BioLab is $0.53.

  • What is the current market cap of PRISM BioLab?

    The current market capitalization of PRISM BioLab is $19.7M.

  • What is PRISM BioLab’s current revenue?

    The trailing twelve month revenue for PRISM BioLab is $4.77M.

  • Who are PRISM BioLab’s competitors?

    PeptiDream, Ipsen, Protagonist Therapeutics, and Ayala Pharmaceuticals are competitors of PRISM BioLab.

  • What is PRISM BioLab’s annual earnings per share (EPS)?

    PRISM BioLab’s EPS for 12 months was -$0.15.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process